Literature DB >> 17408409

Ethnic differences in cardiovascular risk factors in healthy Caucasian and South Asian individuals with the metabolic syndrome.

R Ajjan1, A M Carter, R Somani, K Kain, P J Grant.   

Abstract

BACKGROUND: The metabolic syndrome is a cluster of atherothrombotic risk factors that are commonly associated with insulin resistance.
OBJECTIVES: The aim of this study was to investigate ethnic differences in insulin resistance and non-traditional cardiovascular risk factors in relation to the International Diabetes Federation (IDF) definition of the metabolic syndrome. PATIENTS AND METHODS: A total of 245 healthy South Asians and 245 age- and sex-matched Caucasians were studied. C-reactive protein (CRP), complement C3, plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator (t-PA) were measured and homeostasis model assessment-insulin resistance (HOMA-IR) was calculated from fasting plasma glucose and insulin levels.
RESULTS: Fifty Caucasian (20%) and 95 (39%) South Asian subjects had the metabolic syndrome as defined by the IDF. In South Asian subjects, HOMA-IR, CRP, C3, PAI-1 and t-PA were significantly higher in subjects with the metabolic syndrome. In contrast, in Caucasian individuals there was no difference in HOMA-IR or C3 levels and only CRP, PAI-1 and t-PA were higher in subjects with the metabolic syndrome. In a logistic regression model, plasma levels of CRP and PAI-1 were independent predictors of the metabolic syndrome in Caucasians, whereas plasma levels of C3 and t-PA as well as HOMA-IR were independent predictors of the metabolic syndrome in South Asian subjects.
CONCLUSIONS: In the cohort of individuals studied, the IDF definition of the metabolic syndrome was associated with insulin resistance in the South Asian but not the Caucasian population. This work also showed ethnic differences in non-traditional cardiovascular risk factors in the presence of the metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17408409     DOI: 10.1111/j.1538-7836.2007.02434.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  17 in total

Review 1.  What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?

Authors:  Giovanni Tarantino; Carmine Finelli
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

2.  Metabolic syndrome in South Asian immigrants: more than low HDL requiring aggressive management.

Authors:  Sunita Dodani; Rebecca Henkhaus; Jo Wick; James Vacek; Kamal Gupta; Lei Dong; Merlin G Butler
Journal:  Lipids Health Dis       Date:  2011-03-16       Impact factor: 3.876

3.  Enhanced complement activation is part of the unfavourable cardiovascular risk profile in South Asians.

Authors:  M A Siezenga; P K Chandie Shaw; R N van der Geest; T E Mollnes; M R Daha; T J Rabelink; S P Berger
Journal:  Clin Exp Immunol       Date:  2009-07       Impact factor: 4.330

4.  Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial).

Authors:  Robert D McBane; Regina M Hardison; Burton E Sobel
Journal:  Am J Cardiol       Date:  2009-11-14       Impact factor: 2.778

5.  Complement Component 3 Is Associated with Metabolic Comorbidities in Older HIV-Positive Adults.

Authors:  Alex K Bryant; Pariya L Fazeli; Scott L Letendre; Ronald J Ellis; Michael Potter; Tricia H Burdo; Kumud K Singh; Dilip V Jeste; Igor Grant; David J Moore
Journal:  AIDS Res Hum Retroviruses       Date:  2015-12-15       Impact factor: 2.205

6.  Lipids in South Asians: Epidemiology and Management.

Authors:  Minhal Makshood; Wendy S Post; Alka M Kanaya
Journal:  Curr Cardiovasc Risk Rep       Date:  2019-07-11

7.  Study of beta-cell function (by HOMA model) in metabolic syndrome.

Authors:  M K Garg; M K Dutta; Namita Mahalle
Journal:  Indian J Endocrinol Metab       Date:  2011-07

8.  Adipokines (adiponectin and plasminogen activator inhhibitor-1) in metabolic syndrome.

Authors:  M K Garg; M K Dutta; Namita Mahalle
Journal:  Indian J Endocrinol Metab       Date:  2012-01

9.  Huang-lian-jie-du-tang protects rats from cardiac damages induced by metabolic disorder by improving inflammation-mediated insulin resistance.

Authors:  Chuan Bao Li; Xiao Xing Li; Yu Guo Chen; Hai Qing Gao; Pei Li Bu; Yun Zhang; Xiao Ping Ji
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

Review 10.  Obesity and dyslipidemia in South Asians.

Authors:  Anoop Misra; Usha Shrivastava
Journal:  Nutrients       Date:  2013-07-16       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.